A Static Magnetic Field Inhibits the Migration and Telomerase Function of Mouse Breast Cancer Cells

Zhu Fan1, Pingdong Hu2,3, Lekang Xiang1

  • 1School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.

Insights

Static magnetic field (SMF) therapy may treat cancer by affecting cell proliferation and migration. SMF impacts telomere length and telomerase reverse transcriptase (TERT) expression, suggesting a potential therapeutic target.

Area of Science:

  • Oncology
  • Biophysics

Background:

  • Static magnetic fields (SMF) show potential for cancer therapy by inhibiting cancer cell proliferation.
  • Mechanisms of SMF action, especially on metastasis, require further investigation.

Purpose of the Study:

  • To evaluate the effects of moderate SMF (~150 mT) on 4T1 breast cancer cell proliferation and migration.
  • To elucidate the underlying molecular mechanisms of SMF's impact on cancer cells.

Main Methods:

  • Exposure of 4T1 breast cancer cells to ~150 mT SMF.
  • Assessment of cell proliferation and migration.
  • Analysis of telomere length, telomerase activity, and telomerase reverse transcriptase (TERT) expression.
  • Investigation of e2f1 expression levels.

Main Results:

  • SMF treatment accelerated 4T1 cell proliferation but inhibited cell migration.
  • SMF exposure shortened telomere length and decreased telomerase activity.
  • SMF inhibited telomerase reverse transcriptase (TERT) expression, potentially linked to e2f1 upregulation.
  • SMF repressed both cell migration and telomerase function.

Conclusions:

  • SMF affects cancer cell proliferation and migration, with implications for metastasis.
  • The telomerase network is responsive to SMF, indicating its role in SMF-mediated anti-cancer effects.
  • Telomerase may serve as a therapeutic target in magnetic field cancer therapy.